In cisplatin-induced AKI, the reduction in miR-155 levels attenuates TEC apoptosis and DNA damage by upregulating telomeric repeat binding factor 1 (TRF1) and cyclin-dependent kinase 12 (CDK12), ultimately preventing telomere dysfunction and genomic DNA damage [98]. Here, TERF1 is linked to acute kidney injury.